Urinary Incontinence is a stigmatized, under-reported, under-diagnosed, under-treated condition that is erroneously thought to be a normal part of aging. Urinary Incontinence affects 200 million people worldwide. Based on expert opinion, in excess of 25 million adult Americans experience transient or chronic Urinary Incontinence. Only one in eight Americans who have experienced loss of bladder control have been diagnosed. Men are less likely to be diagnosed than women. Two-thirds of individuals who experience loss of bladder control symptoms do not use any treatment or product to manage their incontinence.
PFCA estimates that the ExMI device treatment methodology developed by Prof. Dr. Michael Jordan, MD can address a patient population in excess of 1 billion people.
Nothing other than a chair, your patients sit fully clothed in this comfortable Italian leather chair. Patients will feel a small vibration or tapping while sitting in the chair. They will even be able to feel there pelvic floor muscles contracting.
A treatment session takes around 20 minutes and is typically done every second day in the doctor’s office. Usually there will be an improvement after 6-8 sessions. The maximal outcome will be achieved after 20 to 26 sessions based on individual diagnosis.
For most patients, a significant improvement is realized. For some patients a complete response is possible. Individual results may vary based on appropriate diagnosis.
Therapy is based on a revolutionary technology called Extracorporeal Magnetic Innervations (ExMI™). This technology produces highly focused time varying magnetic filed which penetrates deep into the perineum, activating the pelvic floor muscles by stimulating all branches of the pudental and splanchinc nerves.
Pulses of sleep gradient magnetic flux are produced and focused by the specially designed therapy head. These fields pass through clothing, bone and soft tissues to initiate nerve impulses. the time varying magnetic field creates an electrical potential which causes ion flow, or Eddy currents, in the soft tissues of the pelvic floor. This ion flow results in a brief depolarization of resting motor neurons. When a threshold is reached, an action potential is initiated for that neuron. This action potential then propagates naturally down the axon via the usual Na+ and K+ ion flows. Once these impulses reach the motor end plates, the muscles of the pelvic floor respond by contracting at a rate equal to the output pulse rate of the therapy head. The muscles contract and relax with each pulse, unless the output pulse rate exceeds the muscles’ ability to contract and relax, resulting in a constant, or tetanic contraction of the muscles.
Simply put, ExMI™ technology induces a nerve impulse, which causes contractions of the pelvic floor and sphincter muscles.
- Role of ExMI in treatement of urinary incontinence
- After Radical Prostatectomy
- ExMI: The French Experience
- Non-invasive therapy may help preserve continence
- (EXMI™) For Treatment of Urinary Incontinence Following RP
- Efficacy of ExMI in the Treatment of stress and Urge Incontinence
- Improve Quality-of-Life for Urinary Incontinence Sufferers
- Neuromodulation Therapies for Lower Urinary Tract Symptoms